Genflow Biosciences PLC Announces International Patent Publication

April 13, 2026 2:10 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a European-based biotechnology company focused on the development of gene therapies for age-related diseases, is pleased to announce the international publication of its Patent Cooperation Treaty (PCT) application, WO 2026/062177 A1, entitled "Variants of Sirtuin 6 for the Treatment of Muscular Diseases."The published PCT application relates to variants of SIRT6 for...

Read more

Court Rules Against Jason Shurka in EESystem Case; $54,034 in Federal Sanctions Ordered

April 11, 2026 5:00 PM

A Clark County District Court judge has ruled against Jason Shurka in an ongoing case brought by Energy Enhancement System, LLC. Judge Timothy C. Williams denied Shurka's anti-SLAPP motion to dismiss in its entirety, finding that his public statements about EESystem were "not made in good faith" and "were made with knowledge of their falsehood" (Case No. A-25-910216-B). In separate federal proceedings in Florida and Nevada, courts ordered Shurka...

Read more

Seniors Being Used As CBD Guinea Pigs In CMS Program?

April 11, 2026 3:45 PM

MMJ International Holdings, Inc. (MMJIH), a leading developer of pharmaceutical-grade cannabinoid therapeutics for Huntington's disease and Multiple Sclerosis, today confirmed that it has moved to join litigation challenging a new federal pilot program that permits discussion and furnishing of hemp-derived cannabinoid products to Medicare beneficiaries without FDA drug approval. The lawsuit, filed in the U.S. District Court for the District...

Read more

Releaf Crosses 25,000 Patients With Record Revenue

April 10, 2026 9:55 AM

When Releaf launched, the UK medical cannabis market was being run almost exclusively by people who believed in the product, but what was missing was anyone who believed in the patient.That gap is now closing. Releaf, the UK's fastest-growing medical cannabis clinic, has surpassed 25,000 patients. The figures are striking, but for the team behind them, they represent something more specific- 25,000 people who had run out of road with...

Read more

Releaf Crosses 25,000 Patients With Record Revenue

April 10, 2026 9:55 AM

When Releaf launched, the UK medical cannabis market was being run almost exclusively by people who believed in the product, but what was missing was anyone who believed in the patient.That gap is now closing. Releaf, the UK's fastest-growing medical cannabis clinic, has surpassed 25,000 patients. The figures are striking, but for the team behind them, they represent something more specific- 25,000 people who had run out of road with...

Read more

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

April 10, 2026 9:40 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today confirmed that the ongoing conflict in Iran and broader Middle East geopolitical tensions have not had a material impact on the Company's operations, supply chain, or business performance. The Company also noted continued record revenue momentum and reaffirmed that its U.S. expansion, including the rollout of...

Read more

How CVS Health Supports Better Heart Health

April 10, 2026 9:00 AM

Key pointsHeart disease is the leading cause of death in the U.S.-yet it can often be prevented.CVS Health is helping people stay heart healthy with convenient preventive screenings, lifestyle support and primary care.We're also making it simpler for people with heart disease to stay on track with their care plans.Originally published on CVS Health Company NewsEvery 34 seconds, someone in the U.S. loses their life to heart disease. But with the...

Read more

Monthly Update March - ADDA in Effect and Preparations for the Next Growth Phase

April 10, 2026 2:45 AM

iZafe Group (STO:IZAFE-B) - March has been a month where several important milestones have been achieved for iZafe Group. The ADDA framework agreement has now come into effect in Sweden, we are seeing clear commercial breakthroughs across multiple markets, and we continue to strengthen the organization to meet increasing demand. We are currently in a phase where many activities are progressing in parallel. Several deals are now materializing...

Read more

Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates

April 9, 2026 8:15 PM

Jaguar Health, Inc.(NASDAQ:JAGX)Participation Instructions for WebcastWhen: Friday, April 10, 2026 at 8:30 a.m. EasternParticipant Registration & Access Link: Click HereReplay Instructions for WebcastReplay of the webcast on the investor relations section of Jaguar's website: (click here)About the Jaguar Health Family of CompaniesJaguar Health, Inc. ("Jaguar") develops novel proprietary prescription drugs sustainably derived from plants for...

Read more

MMJ International Holdings Enters Legal Fight Over CMS Hemp Pilot

April 9, 2026 6:30 PM

MMJ Holdings Throws Its Weight Into the Legal FightA cannabis biopharma company is seeking to join the federal lawsuit challenging the Centers for Medicare & Medicaid Services' (CMS) new hemp and CBD pilot program, adding a pharmaceutical voice to a government-sanctioned program allowing untested and unregulated hemp products into the marketplace. MMJ International Holdings and its subsidiaries, MMJ BioPharma Labs and MMJ BioPharma Cultivation,...

Read more

Queue Ventures Announces TSX Conditional Approval

April 9, 2026 5:55 PM

Queue Ventures Ltd. ("Queue" or the "Company") is pleased to announce that the Company has obtained conditional approval from the Toronto Stock Exchange (the "TSX") in respect of the listing of the common shares of Queue following the completion of its proposed statutory plan of arrangement and related transactions (the "Transaction") with Custom Health, Inc. ("Custom Health"), previously announced on May 30, 2025.Completion of the Transaction...

Read more

Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026

April 9, 2026 1:40 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a global leader in clinically relevant oncology research models and translational solutions, today announced it will present new data across eight poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting, taking place April 17-22, 2026, in San Diego, California.The presentations will highlight research across key areas of oncology drug development, including...

Read more

United Way of South Hampton Roads and Birdsong Health Literacy Center of Excellence Launch Strategic Partnership to Transform Health Literacy Across Hampton Roads

April 9, 2026 12:15 PM

The Birdsong Health Literacy Center of Excellence (Birdsong HLCOE) and United Way of South Hampton Roads today announced a strategic partnership designed to advance the Healthier757 initiative by expanding access to critical health literacy resources and improve health outcomes across the Hampton Roads region.This collaboration brings together the innovation of the Birdsong HCLOE-EdLogics mission-driven partnership with the trusted leadership,...

Read more

Annual Report 2025: Orviglance NDA submitted to the FDA, PDUFA-date set for July 2026

April 9, 2026 11:15 AM

Ascelia Pharma (STO:ACE) today published its Annual Report 2025, which is now available on the company's website.Magnus Corfitzen, CEO, Ascelia Pharma, says:Following the Orviglance New Drug Application (NDA) submission in September 2025, we received the US Food and Drug Administration (FDA) Day 74 letter in November, which formally accepted our NDA for review, aiming for a decision by 3 July 2026 as the PDUFA date. This milestone underscores...

Read more

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

April 9, 2026 9:00 AM

Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced U.S. Food and Drug Administration ("FDA") 510(k) clearance for its next-generation Pivot tubeless insulin patch pump. This milestone clears the path for commercial availability, with initial customer shipments planned by the end of Q2 2026.The Pivot is the first two-part tubeless patch pump featuring...

Read more

CVS Health: Thank You! Gussie Belle Commons Grand Opening Salem, Oregon

April 9, 2026 9:00 AM

On March 11, 2026, CVS Health proudly celebrated the Grand Opening of Gussie Belle Commons in Salem, Oregon, alongside our valued colleagues, local leaders, community organizations, development partners, and residents. The event marked the opening of a new community featuring 120 intentionally designed affordable housing units for families earning up to 30% and 60% of the Area Median Income (AMI).Co-developers Home First and Green Light...

Read more

Ankle & Foot Centers of America Recognizes Foot Health Awareness Month and Hosts Annual Physicians Meeting

April 9, 2026 9:00 AM

Ankle & Foot Centers of America is highlighting the importance of proactive foot care as part of Foot Health Awareness Month this April. The organization is encouraging patients to prioritize foot health, recognize early warning signs of common conditions, and seek timely care to prevent more serious complications. Foot health plays a critical role in overall wellness, yet it is often overlooked. Conditions such as heel pain, bunions, sports...

Read more

Medical Care Technologies Seeks Influencer Partnerships Following Snapshot Recipes Revenue Milestone

April 9, 2026 8:30 AM

Medical Care Technologies, Inc. (OTC Pink:MDCE) today announced the launch of a social media influencer and strategic partnership initiative designed to accelerate user acquisition and scale its growing portfolio of AI-powered mobile applications. Following the successful monetization of its flagship app, Snapshot Recipes, the Company has officially entered the revenue-generating phase of its AI technology platform-marking a significant...

Read more

Senzime Secures Strategic Hospital Orders Within Leading US Integrated Healthcare Delivery Network

April 9, 2026 8:10 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has secured strategic contracts to supply hospitals within one of the world's largest integrated healthcare networks (IDN), encompassing a potential of more than 150 hospitals across the United States. The initial phase includes deliveries of TetraGraph systems to a first group of hospitals within the network, marking the beginning of what has the potential to become Senzime's...

Read more

Hypha Labs, Inc. (OTCQB:FUNI) Announces Partnership with Mycology Resources, LLC

April 9, 2026 8:00 AM

Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator in the functional mushroom sector, today announced the execution of a partnership agreement with Mycology Resources, LLC, a leader in advanced mushroom cultivation, extraction, and global product distribution.The partnership combines Hypha Labs' proprietary Mushroom Accelerator technology and MicroPearls™ delivery system with Mycology Resources' scientific cultivation expertise, ingredient...

Read more